Follow the 오스테오닉 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 오스테오닉 has recorded 88 insider filings. Market capitalisation: €99bn. The latest transaction was disclosed on 8 June 2026 (Purchase). Among the most active insiders: 이동원. The full history is free.
87
Insider Decl.
n/a
Thresholds
n/a
9 ops.
Buy Volume
n/a
6 ops.
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 6,276 of 28,134 companies
65.5
score / 100
Value
61
Quality
70
FCF yld0.1%
Earn yld7.4%
EV/EBITDA9.3x
ROE14%
Gross mgn49%
Net mgn17%
Debt/EBITDA1.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Osteonic is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in developing innovative solutions for the treatment of bone diseases.